Author

P Morinière

Observed names: Morinière, Philippe, P Moriniere, P Moriniére, P. Moriniere, P. Morinière, PHILIPPE MORINIERE, Philippe H. Morinière, Philippe Moriniere, Philippe Morinière

Institution: Assistance Publique Hôpitaux de Marseille

Observed institutions: Centre National de la Recherche Scientifique, St George's Hospital, Inserm, St George's, University of London, Assistance Publique Hôpitaux de Marseille, Centre Hospitalier Universitaire Amiens-Picardie, Hôpital Lariboisière, Institut Cochin, Hôpital Saint-Vincent-de-Paul, Université de Picardie Jules Verne, KU Leuven

OpenAlex ID: A5109171981

Comparison of Intact, Midregion, and Carboxy Terminal Assays of Parathyroid Hormone for the Diagnosis of Bone Disease in Hemodialyzed Patients

1991 · MARTINE-ESTHER COHEN SOLAL, JEAN-LUC SEBERT, et al. · The Journal of Clinical Endocrinology & Metabolism · 152

Is low plasma 25-(OH)vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol?

1999 · Abderhaman Ghazali, Patrice Fardellone, et al. · Kidney International · 151

Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients

2020 · Cécile Couchoud, Florian Bayer, et al. · Kidney International · 148

PDF

Hemodialysis in the treatment of lactic acidosis in diabetics treated by metformin: a study of metformin elimination.

1989 · J D Lalau, M Andrejak, et al. · PubMed · 96

Calcium carbonate, an aluminum-free agent for control of hyperphosphatemia, hypocalcemia, and hyperparathyroidism in uremia.

1986 · A Fournier, P Moriniere, et al. · PubMed · 92

Substitution of aluminium hydroxide by high doses of calcium carbonate in patients on chronic haemodialysis: disappearance of hyperaluminaemia and equal control of hyperparathyroidism.

1983 · P Moriniere, A Roussel, et al. · PubMed · 67

Use of Permcath (Quinton) Catheter in Uraemic Patients in Whom the Creation of Conventional Vascular Access for Haemodialysis Is Difficult

2008 · Thierry Pourchez, Philippe Morinière, et al. · The Nephron journals/Nephron journals · 46

Renal Osteodystrophy in Dialysis Patients: Diagnosis and Treatment

1998 · Albert Fournier, Roxana Oprisiu, et al. · Artificial Organs · 41

Evaluation of Vascular Calcinosis Risk Factors in Patients on Chronic Hemodialysis: Lack of Influence of Calcium Carbonate

2008 · H. Renaud, A. Atik, et al. · The Nephron journals/Nephron journals · 28

Invasive versus non-invasive diagnosis of renal bone disease

1997 · Albert Fournier, Roxana Oprisiu, et al. · Current Opinion in Nephrology & Hypertension · 23

Reappraisal of 2003 NKF-K/DOQI guidelines for management of hyperparathyroidism in chronic kidney disease patients

2006 · Matthieu Monge, Irina Shahapuni, et al. · Nature Reviews Nephrology · 22

A Comparison of Bicarbonate Kinetics and Acid-base Status in High Flux Hemodialysis and On-Line Post-Dilution Hemodiafiltration

2012 · Hélène Morel, Michel Y. Jaffrin, et al. · The International Journal of Artificial Organs · 21

Viewpoint: How Do Calcimimetics Fit Into the Management of Parathyroid Hormone, Calcium, and Phosphate Disturbances in Dialysis Patients?

2005 · Irina Shahapuni, Janet Mansour, et al. · Seminars in Dialysis · 20

Plasma bone Gla-protein: assessment of its clinical value as an index of bone formation in hemodialyzed patients.

1987 · J L Sebert, J C Ruiz, et al. · PubMed · 18

Drug Insight: renal indications of calcimimetics

2006 · Irina Shahapuni, Matthieu Monge, et al. · Nature Reviews Nephrology · 16

Percutaneous recanalization of occlusion of central and proximal veins in chronic hemodialysis: Technical Note

1997 · Philippe Morinière, Romualdine Rodary-Vautier, et al. · Kidney International · 12

PDF

The clinical significance of adynamic bone disease in uremia.

1997 · A Fournier, S Said, et al. · PubMed · 11

Improvement of severe secondary hyperparathyroidism in dialysis patients by intravenous 1 alpha(OH) vitamin D3, oral CaCO3 and low dialysate calcium.

1993 · P Moriniere, N el Esper, et al. · PubMed · 9

The new treatments of hyperparathyroidism secondary to renal insufficiency.

1992 · A Fournier, T Drüeke, et al. · PubMed · 9

[Renal osteodystrophy (3); its treatment in dialysis patients].

2000 · S Ghitu, R Oprisiu, et al. · PubMed · 7

[Hemodialysis and strongyloidiasis: a presumed cause of eosinophilia able to mask the other].

1999 · S Saïd, G Nevez, et al. · PubMed · 7

Determination of aluminium in bone in haemodialyzed patients, using inductively coupled argon plasma emission spectrometry

1990 · P. Leflon, R. Plaquet, et al. · Clinica Chimica Acta · 7

[Does 24,25 dihydroxycholecalciferol have a physiological and pathophysiological role?].

1982 · J L Sebert, A Fournier, et al. · PubMed · 6

Calcimetic AMG 073 at 50 and 100 mg per day

2003 · Janette Mansour, Mohamed Benyahia, et al. · Kidney International · 4

Renal Osteodystrophy: General Concepts and Current Issues

1984 · Albert Fournier, Philippe Morinière, et al. · Springer eBooks · 4

Works count: 79

Citation count: 1,067

H-index: 15

I10-index: 17